Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-11-046969

← back to feed
Filed
Aug 15, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 11, 2011 21.49M sh
Capex Q2 2011 · Jun 30, 2011 $2.86K
Capex Q2 2011 · Jun 30, 2010 $0
Stockholders Equity Q2 2011 · Jun 30, 2011 $529.25K
Stockholders Equity Q2 2011 · Dec 31, 2010 $1.66M
Current Liabilities Q2 2011 · Jun 30, 2011 $2.26M
Current Liabilities Q2 2011 · Dec 31, 2010 $1.89M
Current Assets Q2 2011 · Jun 30, 2011 $2.78M
Current Assets Q2 2011 · Dec 31, 2010 $3.53M
Total Assets Q2 2011 · Jun 30, 2011 $2.79M
Total Assets Q2 2011 · Dec 31, 2010 $3.55M
Net Income Q2 2011 · Jun 30, 2011 −$577.93K
Net Income Q2 2011 · Jun 30, 2011 −$1.32M
Net Income Q2 2011 · Jun 30, 2010 −$694.15K
Net Income Q2 2011 · Jun 30, 2010 −$974.63K
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$402.02K
Cash And Equivalents Q2 2011 · Jun 30, 2010 $84.42K
Cash And Equivalents Q2 2011 · Dec 31, 2009 $108.99K
Sga Expense Q2 2011 · Jun 30, 2010 $386.78K
Sga Expense Q2 2011 · Jun 30, 2010 $704.08K
Rd Expense Q2 2011 · Jun 30, 2010 $152.61K
Rd Expense Q2 2011 · Jun 30, 2010 $255.62K
Operating Income Q2 2011 · Jun 30, 2010 −$539.39K
Operating Income Q2 2011 · Jun 30, 2010 −$959.69K
Revenue Q2 2011 · Jun 30, 2010 $0
Revenue Q2 2011 · Jun 30, 2010 $0